Neurogene (NGNE) Q2 2026 Earnings

12MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.39
-1.26
-1.12
-0.99

Details

Expected EPS
-1.29625
Actual EPS
-1.39
Surprise EPS
-0.09
Surprise Percent
+7.23%

Description

Neurogene (NGNE) has reported earnings of -1.39 per share for Q2 2026.

0 Comments

Share your thoughts